Product Information
TOBRAMYCIN-DEXAMETH OPHTH SUSP is a generic product labeled by Bausch & Lomb Incorporated, priced at $4.2681 per ML under NDC 24208029505. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 27, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1; 3 mg/mL; mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208029505
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
DEXAMETHASONE; TOBRAMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA064134FDA Approved
10/27/1999
TE Code
AB
On Market Since
10/27/1999
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 75.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.2681 per ML |
|---|---|
| All-time high | $17.7355 (Apr 16, 2014) |
| All-time low | $3.7216 (Jul 17, 2024) |
| 52-week high | $4.7783 |
| 52-week low | $4.1809 |
| Median price | $14.0599 |
| Average price | $12.0968 |
| Largest weekly change | +49.3% (Nov 22, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOBRAMYCIN-DEXAMETH OPHTH SUSP?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN-DEXAMETH OPHTH SUSP, manufactured by Bausch & Lomb Incorporated, is $4.2681 per ML (NDC 24208029505), effective Aug 19, 2026.
How has the price of TOBRAMYCIN-DEXAMETH OPHTH SUSP changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has declined 75.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN-DEXAMETH OPHTH SUSP?
Since Nov 28, 2013, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has ranged from a low of $3.7216 (Jul 17, 2024) to a high of $17.7355 (Apr 16, 2014), with a median of $14.0599 per ML.
Are there cheaper alternatives to TOBRAMYCIN-DEXAMETH OPHTH SUSP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOBRAMYCIN-DEXAMETH OPHTH SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures TOBRAMYCIN-DEXAMETH OPHTH SUSP?
TOBRAMYCIN-DEXAMETH OPHTH SUSP (NDC 24208029505) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.